MedScout, Inc.

Based in the US, MedScout, Inc. specializes in leveraging healthcare claims data to provide actionable insights for medical sales and marketing teams, enhancing their strategies and engagement with healthcare providers. MedScout, Inc. was founded in 2021 in Texas, US.

The company focuses on transforming healthcare claims data into insights for medical sales teams. The founders include Casey Shattuck, Skylar Talley, and Thorsten Bleich, with Skylar Talley serving as the CEO. Its core product combines proprietary datasets from Medicare and Commercial payers, encompassing over 310 million unique patients in the United States. The platform translates raw claims data—amounting to more than 34 billion records—into clear, targeted insights that enable sales teams to optimize their strategies at every stage of the commercial cycle.

The service is especially valuable to medical sales professionals, including sales representatives, account managers, and territory managers, who leverage the platform to enhance their engagement with physicians by identifying high-potential targets and tailoring their outreach. MedScout primarily serves the healthcare market across the United States, where it helps medical sales teams streamline their processes, improve efficiency, and deliver unparalleled value to physicians. MedScout generates revenue through a subscription-based model that provides clients access to its comprehensive data insights and analytics tools. Clients encompass a diverse range of healthcare organizations, including medical device companies and pharmaceutical firms, which utilize the platform to inform their sales strategies and marketing campaigns.

The transactions typically involve annual or monthly subscriptions, allowing users to continuously access updated claims data and insights that support their sales efforts. MedScout’s pricing structure is designed to accommodate different levels of service, tailored to the specific needs of its clients. The platform’s significant user engagement indicates its value proposition within the medical sales landscape, reinforcing the company's role as an indispensable resource for healthcare sales teams seeking to enhance their operational effectiveness. In February 2026, MedScout, Inc.

raised USD 10 million in growth funding led by Fulcrum Equity Partners, with participation from LiveOak Venture and Stage 2 Capital. The company plans to use the February 2026 funding to further develop its AI agents, support enterprise customer needs, and expand its team to scale its commercial software for medical technology companies.